Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

  • Log out

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
  • Log out
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube

Shared Decision-Making and Discontinuation of Opioid Therapy for Chronic Pain

ORIGINAL RESEARCH

John C. Licciardone, DO, MS, MBA; Michaela Digilio, MS; Subhash Aryal, PhD

Corresponding Author: John C. Licciardone, DO, MS, MBA; University of North Texas Health Science Center 

Email: john.licciardone@unthsc.edu

DOI: 10.3122/jabfm.2024.240290R1

Keywords: Analgesics, Chronic Pain, Communication, Low Back Pain, Opioid, Pain Management, Patient-Centered Care, Pharmacology, Physician's Practice Patterns, Propensity Score, Quality of Life, Shared Decision-Making, Surveys and Questionnaires

Dates: Submitted: 08-02-2024; Revised: 10-19-2024; Accepted: 11-04-2024

Status: In production for ahead of print. 

BACKGROUND: Research is needed to measure the effects of shared decision-making (SDM) on discontinuation of opioid therapy for chronic pain.

DESIGN: Target trial emulation.

SETTING: National pain research registry from September 2016 to January 2024.

PARTICIPANTS: 328 patients currently using opioid therapy for chronic low back pain at baseline, including 164 patients each in greater and lesser SDM groups matched on propensity scores.

MEASUREMENTS: SDM was measured with the Communication Behavior Questionnaire. Primary outcomes involving discontinuation of opioid therapy and opioid prescribing frequency and secondary outcomes of pain, function, and health-related quality of life were measured over 12 months.

RESULTS: The mean (SD) age of patients was 56.1 (SD, 11.1) years and 239 (72.9%) were female. During 1178 quarterly encounters, greater SDM was associated with less frequent discontinuation of opioid therapy 3 months post-baseline (RR, 0.56; 95% CI, 0.37-0.86; P=0.006) and more frequent opioid prescribing 3 to 12 months post-baseline (RR, 1.24; 95% CI, 1.11-1.38: P<0.001). Although greater SDM was associated with worse physical function, and opioid therapy was associated with greater back-related disability and worse physical function, these results were not clinically important. SDM opioid therapy interaction effects were not observed, indicating that more frequent use of opioid therapy with SDM did not yield better outcomes.

CONCLUSIONS: SDM was associated with less frequent short-term discontinuation of opioid therapy and more frequent long-term opioid prescribing that was not associated with better outcomes. Thus, SDM is necessary but insufficient to improve opioid prescribing for patients with chronic pain. 

ABSTRACTS IN PRESS

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire